南美和中美色素沉着症治疗市场预测至 2030 年 - 区域分析 - 按治疗类型（药妆、光疗或激光疗法、微晶换肤术、化学换肤术、冷冻疗法等）、病症（黄褐斑、日光性雀斑、炎症后色素沉着等）和最终用户（医院、皮肤病中心等）

Historic Data: 2020-2021   |   Base Year:    |   Forecast Period: 2023-2030

No. of Pages: 80    |    Report Code: BMIRE00031386    |    Category: Life Sciences

Explore in Your Language
English Spanish Korean Japanese Italian German French Arabic
South & Central America Hyperpigmentation Disorder Treatment Market
Free Sample Buy Now
2022 年，南美和中美洲色素沉着症治疗市场价值为 8.8776 亿美元，预计到 2030 年将达到 14.8428 亿美元；预计 2022 年至 2030 年的复合年增长率为 6.6%。

黄褐斑患病率上升推动南美和中美洲色素沉着症治疗市场发展

黄褐斑是最主要的色素沉着症之一，其特征是面部出现对称的浅色至深色泥褐色斑块，边界清晰，尤其是下巴、上唇、鼻子、前额和脸颊。它在女性和肤色较黑的人群中很常见。颧骨、下颌和面部中央的临床特征在黄褐斑中很常见。日晒、荷尔蒙变化、怀孕、遗传因素、化妆品和药物都与黄褐斑的形成有关。各种研究估计，黄褐斑在普通人群中的总体患病率为 1% 至 50%。55–64% 的黄褐斑病例报告有相同疾病的家族史。

怀孕是黄褐斑的另一个常见原因。这种情况也会影响服用口服避孕药和激素的女性。雌激素、孕酮和促黑素细胞激素水平通常在妊娠晚期升高，这可能是一个因素。根据美国国家生物技术信息中心 (NCBI) 2023 年 8 月的数据，黄褐斑在育龄妇女中更为常见，很少在青春期前发生；15–50% 的孕妇会出现这种情况，其患病率为 1.5% 至 33%，具体取决于不同地区的人口。因此，黄褐斑患病率的上升引发了对色素沉着治疗的需求。

南美和中美洲色素沉着症治疗市场概览

由于色素沉着病例数量的增加，巴西的色素沉着症治疗市场正在经历显着增长。根据《皮肤与干细胞杂志》 2022 年 1 月发表的一篇文章，色素沉着表型在东南亚、中东、地中海、西班牙裔美国人和巴西人群中的患病率较高。文章中介绍的一项巴西研究得出结论，在 57,343 名患者中，黄褐斑是皮肤相关咨询的第三大最常见原因。

此外，随着巴西医疗支出的扩大，分配给皮肤病护理的投资和资源也相应增加，包括产品开发活动和有效痤疮药物的推广。资金支持增强了研发力度，促进了先进配方和治疗方案在该国市场的引入。医疗服务的可及性提高和皮肤护理意识的增强进一步增强了全国对色素沉着症治疗的需求。

南美洲和中美洲色素沉着症治疗市场收入及预测至 2030 年（百万美元）

南美洲和中美洲色素沉着症治疗市场细分

南美洲和中美洲色素沉着症治疗市场分为治疗类型、病症、最终用户和国家。

按治疗类型，南美洲和中美洲色素沉着症治疗市场分为药妆、光或激光疗法、微晶换肤术、化学换肤、冷冻疗法等。 2023 年，药妆品部分在南美和中美色素沉着症治疗市场中占有最大份额。

就条件而言，南美和中美色素沉着症治疗市场细分为黄褐斑、日光性雀斑、炎症后色素沉着等。2023 年，黄褐斑部分在南美和中美色素沉着症治疗市场中占有最大份额。

按最终用户划分，南美和中美色素沉着症治疗市场包括医院、皮肤病中心等。2023 年，医院部分在南美和中美色素沉着症治疗市场中占有最大份额。

根据国家/地区，南美和中美色素沉着症治疗市场细分为巴西、阿根廷和南美和中美洲其他地区。 2023 年，巴西占据了南美和中美色素沉着症治疗市场的最大份额。

AbbVie Inc、Bayer AG、Galderma SA、L\'OREAL SA、Lutronic Co Ltd、Obagi Cosmeceuticals LLC 和 Pierre Fabre SA 是南美和中美色素沉着症治疗市场的一些领先公司。

South & Central America Hyperpigmentation Disorder Treatment Strategic Insights

Strategic insights for South & Central America Hyperpigmentation Disorder Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/south-and-central-america-hyperpigmentation-disorder-treatment-market-strategic-framework.webp
Get more information on this report

South & Central America Hyperpigmentation Disorder Treatment Report Scope

Report Attribute Details
Market size in 2022 年为 8.8776 亿美元
Market Size by 到 2030 年将达到 14.8428 亿美元
Global CAGR ()
Historical Data 2020-2021
Forecast period 2023-2030
Segments Covered By 治疗类型
  • 药妆
  • 光疗或激光疗法
  • 微晶换肤术
  • 化学换肤术
  • 冷冻疗法
By 病症
  • 黄褐斑
  • 日光性雀斑
  • 炎症后色素沉着
By 最终用户
  • 医院
  • 皮肤病中心
Regions and Countries Covered 南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
Market leaders and key company profiles
  • AbbVie Inc
  • Bayer AG
  • Galderma SA
  • LOREAL S.A.
  • Lutronic Co Ltd
  • Obagi Cosmeceuticals LLC
  • Pierre Fabre SA
    		•
    Get more information on this report

    South & Central America Hyperpigmentation Disorder Treatment Regional Insights

    The regional scope of South & Central America Hyperpigmentation Disorder Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/south-and-central-america-hyperpigmentation-disorder-treatment-market-geography.webp
    Get more information on this report
    Identical Market Reports with other Region/Countries

    The List of Companies - South & Central America Hyperpigmentation Disorder Treatment Market

    • AbbVie Inc
    • Bayer AG
    • Galderma SA
    • L'OREAL S.A.
    • Lutronic Co Ltd
    • Obagi Cosmeceuticals LLC
    • Pierre Fabre SA
    Frequently Asked Questions
    How big is the South & Central America Hyperpigmentation Disorder Treatment Market?

    The South & Central America Hyperpigmentation Disorder Treatment Market is valued at 2022 年为 8.8776 亿美元 in , it is projected to reach 到 2030 年将达到 14.8428 亿美元 by .

    What is the CAGR for South & Central America Hyperpigmentation Disorder Treatment Market by ()?

    As per our report South & Central America Hyperpigmentation Disorder Treatment Market, the market size is valued at 2022 年为 8.8776 亿美元 in , projecting it to reach 到 2030 年将达到 14.8428 亿美元 by . This translates to a CAGR of approximately during the forecast period.

    What segments are covered in this report?

    The South & Central America Hyperpigmentation Disorder Treatment Market report typically cover these key segments-

  • 治疗类型 (药妆, 光疗或激光疗法, 微晶换肤术, 化学换肤术, 冷冻疗法)
  • 病症 (黄褐斑, 日光性雀斑, 炎症后色素沉着)
  • 最终用户 (医院, 皮肤病中心)

    • What is the historic period, base year, and forecast period taken for South & Central America Hyperpigmentation Disorder Treatment Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Hyperpigmentation Disorder Treatment Market report:

  • Historic Period : 2020-2021
  • Base Year :
  • Forecast Period : 2023-2030
    • Who are the major players in South & Central America Hyperpigmentation Disorder Treatment Market?

    The South & Central America Hyperpigmentation Disorder Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • AbbVie Inc
  • Bayer AG
  • Galderma SA
  • LOREAL S.A.
  • Lutronic Co Ltd
  • Obagi Cosmeceuticals LLC
  • Pierre Fabre SA
    • Who should buy this report?

    The South & Central America Hyperpigmentation Disorder Treatment Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the South & Central America Hyperpigmentation Disorder Treatment Market value chain can benefit from the information contained in a comprehensive market report.

    Available Report Formats

    pdf-format excel-format pptx-format
    Request Free Sample Buy Now
    south-and-central-america-hyperpigmentation-disorder-treatment-market